The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Yi-Fei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Lipoprotein(a), Acute Coronary Syndrome, Tomography, Optical Coherence. Die Arbeit nennt 41 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
The association between lipoprotein(a) [Lp(a)] levels and progression of non‐culprit atherosclerosis (NSA) in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) is unknown.
Methods
This study enrolled 177 patients with ACS who underwent OCT‐guided PCI and follow‐up OCT examinations of non‐culprit lesions between 2013 and 2018. Lesion characteristics including fibrous tissue, calcium, lipid, and macrophage content were assessed using quantitative plaque analysis. High Lp(a) levels were defined as Lp(a) ≥ 30 mg/dL. The association between Lp(a) levels and NSA progression was investigated using linear effect models adjusted for clinical risk factors. A discordance analysis was also performed.
Results
At 1‐year follow‐up, individuals with Lp(a) levels ≥ 30 mg/dL had increased total atheroma volume and lipid component, and higher incidence of thin‐cap fibroatheroma (TCFA) ( p = 0.021; p = 0.006; p = 0.025, respectively). After adjusted, multivariable linear regression model revealed an association between Lp(a) and plaque progression in NSA (7.22 for each 1 SD increase, 95% CI: 0.96–13.48; p = 0.025) and increased lipid component (3.60 for each 1 SD increase, 95% CI: 0.63–6.56; p = 0.019). Discordance analyses showed that individuals with discordantly low Lp(a) levels had the lightest plaque progression and increase in lipid plaque burden (17.34 [10.22, 28.21] vs. 28.73 [14.88, 45.88] versus 25.73 [13.85, 45.70], p = 0.017).
Conclusion
Among patients with ACS, elevated Lp(a) levels were related to the progression of coronary plaques in non‐culprit lesions, including increased total atheroma volume and lipid component, and a higher prevalence of TCFA at follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Yi-Fei Wang, Fei Ye
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Wang, Y. F., Xu, T., You, W., Nong, J. C., Meng, P. N., Wu, X. Q., Wu, Z. M., Feng-Wang, & Ye, F. (2025). The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31596
Vancouver
Wang YF, Xu T, You W, Nong JC, Meng PN, Wu XQ, et al. The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31596
BibTeX
@article{Wang2025,
author = {Wang, Yi-Fei and Xu, Tian and You, Wei and Nong, Jia-Cong and Meng, Pei-Na and Wu, Xiang-Qi and Wu, Zhi-Ming and Feng-Wang and Ye, Fei},
title = {The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31596}
}
EUVIMED